Search - tctmd.com

Displaying 141 - 160 of 1375

Sort: Relevancy | Date

News Daily News

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

Michael O'Riordan

September 24, 2024

News Daily News

Satisfaction With Life Portends Less CVD: UK Biobank Analysis

Caitlin E. Cox

September 20, 2024

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Daily News

Statins Are Cost-effective in the Elderly

Michael O'Riordan

September 11, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Conference News ESC 2024

Trial Challenges Continuation of Oral Anticoagulants During TAVI

Todd Neale

August 31, 2024

News Conference News ESC 2024

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

Caitlin E. Cox

August 31, 2024

News Conference News ESC 2024

Polypills Show Promise in Diverse Hypertensive Patient Groups

L.A. McKeown

August 31, 2024

News Conference News ESC 2024

Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery

Todd Neale

August 30, 2024

News Conference News ESC 2024

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

L.A. McKeown

August 30, 2024

News Daily News

Platelet Hyperreactivity Score May Improve CVD Risk Detection

L.A. McKeown

August 23, 2024

News Daily News

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

Yael L. Maxwell

August 19, 2024

News Daily News

Point-of-Care High-Sensitivity Assay for Troponin I Compares Well With Central Labs

L.A. McKeown

August 15, 2024

News Daily News

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

L.A. McKeown

August 13, 2024

News Daily News

Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources

Todd Neale

August 12, 2024

News Daily News

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Yael L. Maxwell

August 01, 2024

News Daily News

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Michael O'Riordan

July 29, 2024

News Daily News

Schoolwide Intervention May Improve Obesity Outcomes Over Time

Yael L. Maxwell

July 29, 2024

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

Advertisement

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

Satisfaction With Life Portends Less CVD: UK Biobank Analysis

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Statins Are Cost-effective in the Elderly

September 2024 Dispatch for the CV Team

Trial Challenges Continuation of Oral Anticoagulants During TAVI

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

Polypills Show Promise in Diverse Hypertensive Patient Groups

Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

Platelet Hyperreactivity Score May Improve CVD Risk Detection

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

Point-of-Care High-Sensitivity Assay for Troponin I Compares Well With Central Labs

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Schoolwide Intervention May Improve Obesity Outcomes Over Time

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content